Research-grade portfolio
Cells, reagents, extracellular vesicles, and assay products support a range of stem-cell research questions.
Translational research materials • Solution 01
A comprehensive portfolio of human-derived cells, research reagents, and analytical tools designed with reproducible workflows and clinical translation in mind.
Scientific objective first
Stem cells are of exceptional interest in regenerative medicine, drug screening, and large-scale disease modeling because of their roles in cellular and tissue repair, renewal, and regeneration.
Cells, reagents, extracellular vesicles, and assay products support a range of stem-cell research questions.
Materials and tools are selected to support repeatable culture, characterization, and differentiation work.
The portfolio is organized to help teams connect basic discovery with subsequent pre-clinical investigation.

The research context
LeoCorps and affiliated companies provide a stem-cell portfolio designed around the needs of research translation. Reagents support the transition from basic scientific work toward later investigative phases, while instrument platforms for cell isolation, flow cytometry, hematology, and closed-system filling provide complementary laboratory tools.
Explore our standardsFeatured stem-cell portfolio
Open a product to review its available specifications, formats, and purchasing options.
Connected research support
Material sourcing, characterization, quality-focused preparation, and controlled delivery work together to protect research value.
Build around the research need
Share the scientific objective, cell or tissue type, donor requirements, assay needs, processing specifications, documentation, and timeline.